English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 18034/20233 (89%)
造訪人次 : 23367298      線上人數 : 503
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/24226


    標題: Discovery of l-(2,4-dichlorophenyl)4-ethyl-5-(5-(2-(4-(trifluoraethyl) phenyl) ethynyl)thiophen-2-yl)-N-(piperidin-1-yl)-lH-pyrazole-3- carboxamide as A Potential Peripheral Cannabinoid-1 Receptor Inverse Agonist
    作者: Chun-Ping Chang (張竣評)
    Ming-Shiu Hung
    Ting-Chieh Li
    Yinchiu Lin
    Yu-Sheng Chao
    Kak-Shan Shia (夏克山)
    日期: 2011
    上傳時間: 2011-06-23 14:57:17 (UTC+8)
    摘要: A novel class of aryl alkynylthiophene compounds has been designed to target peripheral CB1R to eliminate/minimize CNS side effects as observed with 1, a typical
brain CBlR-acting agent. The titled compound, l-(2,4-dichlorophenyl)-4-ethyl-5-(5-(2-(4-(trifluoromethyl)phenyl)ethynyl)thiophen-2 -yl)-N(piperidin-l-yl)-lH-pyrazole-3-carboxamide (8), is tentatively y recognhized as a peripheral inverse agonist based on its negative central effects in CB1R agonist-induced hypothermia and analgesia models, and low brain exposure (B/P = 1/33) measured at a time point of 2 hours following oral administration. The chronic study of 8 in DIO mice is currently underway. A full account of the in vivo studies, with particular emphasis on addressing issues of central drug accumulation and peripheral metabolic benefits, as well as further SAR studies on the series will be reported elsewhere in due course.
    關聯: 2011年台俄有機、藥物與生物化學交流暨藥物化學研討會,起迄日:2011/04/06~2011/04/05,地點:溪頭台大實驗林
    顯示於類別:[藥理學院] 2011年台俄有機、藥物與生物化學交流暨藥物化學研討會

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    pp-10.pdf67KbAdobe PDF486檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋